Abstract
Purpose. Application of therapeutic ultrasound (frequency: 1–3 MHz and intensity: 0–2 W/cm2) enhances transdermal drug transport, although typically by a factor of less than 10. In this paper, we show that application of ultrasound at 20 KHz induces transdermal transport enhancements of up to 1000 times higher than those induced by therapeutic ultrasound.
Methods. In vitro (human cadaver epidermis) as well as in vivo (hairless rat skin) permeation experiments were performed to assess the effect of low-frequency ultrasound on transdermal transport.
Results. Application of low-frequency ultrasound (20 KHz, 125 mW/cm2, 100 msec pulses applied every second) enhanced transdermal transport of several permeants, including estradiol, salicylic acid, corticosterone, sucrose, aldosterone, water, and butanol, across human cadaver skin by a factor in the range of 3 to 3000 and that of salicylic acid across hairless rat skin in vivo by a factor of up to 300. Low-frequency ultrasound did not induce a long-term loss of the barrier properties of the skin (in vitro) or damage to living skin of hairless rats. At a mechanistic level, it is hypothesized that application of low-frequency ultrasound enhances transdermal transport through aqueous channels in the SC generated by cavitation-induced bilayer disordering. Support for this hypothesis is provided using experimental and theoretical analyses of low-frequency sonophoresis.
Conclusions. Low-frequency ultrasound enhances transdermal transport of drugs more effectively than that induced by therapeutic ultrasound.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
Bronaugh, R. L., Maibach, H. I. (Eds), In “Percutaneous Absorption”, Marcel Dekker (New York), pp 1–12, (1989).
Jarrett, A., (Ed.), “The Physiology and Pathology of the Skin”, Academic Press (London) (1978).
Walters, K. A. In “Transdermal Drug Delivery: Developmental Issues and Research Initiatives”, Hadgraft J., Guy, R. H., Eds., Marcel Dekker (New York), pp. 197–233, (1989).
Junginger, H. E., Bodde. H. E., de Haan de, F. H., N. In: Drug Permeation Enhancement: Hsieh, D.S. (Ed), Marcel Dekker (New York), pp. 59–90, (1994).
Prausnitz, M. R., Bose V., Langer, R., Weaver, J. C., “Electroporation of Mammalian Skin: A Mechanism to enhance Transdermal Drug Delivery”, Proc. Natl. Acad. Sci. USA, 90:10504–10508, (1993).
Kost, J., Piquet U., Mitragotri, S., Yamamoto, A., Weaver, J., Langer, R., “Enhanced Transdermal Delivery: Synergistic effect of Ultrasound and Electroporation”, Pharm. Res., In Press, (1995).
Burnette, R. R. In: Developmental Issues and Research Initiatives: Hadgraft J., Guy, R. H., (Eds), Marcel Dekker (New York), pp. 247–288, (1989).
Mitragotri, S., Edwards, D., Blankschtein D., Langer, R., “A Mechanistic study of Ultrasonically Enhanced Transdermal drug Delivery”, J. Pharm. Sci., 84:697–706, (1995).
Mitragotri, S., Blankschtein, D., Langer, R. In: Encl. of Pharm. Tech.; Swarbrick, J., Boylan, J. (Eds.), Marcel Dekker, In Press, (1995).
Kost, J., Langer, R. In: Topical Drug Bioavailability, Bioequivalence, and Penetration; Shah V. P., Maibach, H. I., Eds., Plennum (New York), pp. 91–103, (1993).
Kost, J., Levy, D., Langer, R. In: Percutaneous Absorption: Mechanisms-Methodology-Drug Delivery; Bronaugh, R., Maibach, H., I. (Eds.), Marcel Dekker (New York), pp. 595–601, (1989).
Gaertner, W., “Frequency Dependence of acoustic Cavitation”, J. Acoust. Soc. Am.,26:977–80, 1954.
Wester R., Maibach, H. I., In: Topical Drug Bioavailability, Bioequivalence, and Penetration; Shah V. P., Maibach, H. I., Eds., Plenum Press: New York, pp: 333–347, (1993).
Flynn, G. L. In: Principles of Route-to-Route Extrapolation for Risk Assessment; Gerrity, T. R., Henry, C. J., Eds., Elsevier (New York), pp. 93–127, (1990).
Walmsley, A. D., “Applications of Ultrasound in Dentistry”, Ultrasound in Med. & Biol., 14:7–14, (1988).
Wells, ‘Biomedical Applications of Ultrasound’, Plenum Press. (New York), 1977.
Suslick, K. S., “Ultrasound: Its Chemical, Physical, and Biological Effects”, VCH Publishers, (1989).
Mitragotri, S., Blankschtein, D., Langer, R., “Ultrasound-Mediated Transdermal Protein Delivery”, Science, 269: 850–853, (1995).
Nyborg, W. L. Mason, W. P., Eds., Academic Press (New York), pp. 265–283, (1965).
Gummer, C. L. In: Transdermal Drug Delivery: Developmental Issues and Research Initiatives; Guy, R. H., Hadgraft, J. (Eds.), Marcel Dekker (New York), pp. 177–197, (1989).
Wertz, P., W., Swrtzendruber, D. C., Downing, D. T., “Composition and Morphology of Epidermal Cyst Lipids”, J. Invest. Dermatol., 89:419–425, (1987).
Allenby A., F. J., Schok C., Tees T. F. S., “The Effect of Heat and Organic Solvents on The Electrical Impedance and Permeability of Excised Human Skin”, Br. J. Derm., 81:31–62, (1961).
Edwards, D., Langer, R., “A Linear Theory of Transdermal transport phenomena”, J. Pharm. Sci, 83:1315–1334, (1994).
Perry, R. H., Green, D. W., “Chemical Engineering Handbook”, McGraw-Hill Book Company, New York, (1973).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mitragotri, S., Blankschtein, D. & Langer, R. Transdermal Drug Delivery Using Low-Frequency Sonophoresis. Pharm Res 13, 411–420 (1996). https://doi.org/10.1023/A:1016096626810
Issue Date:
DOI: https://doi.org/10.1023/A:1016096626810